Travis Mickle
Presidente presso KemPharm Denmark A/S
Patrimonio netto: 261 418 $ in data 31/05/2024
Posizioni attive di Travis Mickle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Presidente | 13/05/2022 | - |
Storia della carriera di Travis Mickle
Precedenti posizioni note di Travis Mickle
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/11/2021 | 25/04/2023 |
| Amministratore Delegato | 01/10/2010 | 25/04/2023 | |
| Presidente | 01/11/2014 | 05/11/2021 | |
| Direttore Tecnico/Scientifico/R&S | 30/10/2006 | 01/10/2010 | |
| Fondatore | 30/10/2006 | 25/04/2023 | |
| Presidente | 30/10/2006 | 25/04/2023 | |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01/01/2002 | 01/10/2005 |
Formazione di Travis Mickle
| University of Iowa | Doctorate Degree |
| Simpson College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Danimarca | 2 |
Posizioni
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |
- Borsa valori
- Insiders
- Travis Mickle
- Esperienza
